References
Loffing J, Flores SY, Staub O (2006) Sgk kinases and their role in epithelial transport. Annu Rev Physiol 68:461–490
McCormick JA, Bhalla V, Pao AC, Pearce D (2005) SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption. Physiology (Bethesda) 20:134–139
Wulff P, Vallon V, Huang DY, Volkl H, Yu F, Richter K, Jansen M, Schlunz M, Klingel K, Loffing J, Kauselmann G, Bosl MR, Lang F, Kuhl D (2002) Impaired renal Na(+) retention in the sgk1-knockout mouse. J Clin Invest 110:1263–1268
Artunc F, Amann K, Nasir O, Friedrich B, Sandulache D, Jahovic N, Risler T, Vallon V, Wulff P, Kuhl D, Lang F (2006) Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1. J Mol Med (in press). DOI 10.1007/s00109-006-0082-0
Quinkler M, Zehnder D, Eardley KS, Lepenies J, Howie AJ, Hughes SV, Cockwell P, Hewison M, Stewart PM (2005) Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation 112:1435–1443
Bhargava A, Pearce D (2004) Mechanisms of mineralocorticoid action: determinants of receptor specificity and actions of regulated gene products. Trends Endocrinol Metab 15:147–153
Feng Y, Wang Y, Xiong J, Liu Z, Yard B, Lang F (2006) Enhanced expression of serum and glucocorticoid-inducible kinase-1 in kidneys of L-NAME-treated rats. Kidney Blood Press Res 29:94–99
Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, Belaiba RS, Gorlach A, Wulff P, Daut J, Dalton ND, Ross J Jr, Flogel U, Schrader J, Osswald H, Kandolf R, Kuhl D, Lang F (2006) SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. J Mol Med 84:396–404
BelAiba RS, Djordjevic T, Bonello S, Artunc F, Lang F, Hess J, Gorlach A (2006) The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circ Res 98(6):828–836
Fuller PJ, Young MJ (2005) Mechanisms of mineralocorticoid action. Hypertension 46:1227–1235
Bianchi S, Bigazzi R, Campese VM (2005) Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. Am J Kidney Dis 46(1):45–51
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709–717
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luft, F.C. The serum- and glucocorticoid-induced kinase in DOCA–salt hypertension. J Mol Med 84, 709–711 (2006). https://doi.org/10.1007/s00109-006-0086-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-006-0086-9